GenixPharmaceucticals Corporation (GENX : TSX-V)
Common Stock
$0.02
CAD
+0.00 (%)
Last updated: 2026-06-17
GENX
GenixPharmaceucticals Corporation
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-20.00%
Key Statistics
Market Cap
$918,361
52W High
$0.04
52W Low
$0.02
P/E Ratio
-
50 Day MA
$0.02
200 Day MA
$0.03
Beta
0.42
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/17/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 6/16/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 6/12/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 5/27/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 5/26/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 5/25/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 5/22/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 9,000 |
| 4/24/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 4/23/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 4/20/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GENX's historical volatility
30-Day Vol
251.3%
Annualized
90-Day Vol
267.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.04 |
| 60 trading days | C$0.02 | C$0.01 – C$0.06 |
| 90 trading days | C$0.02 | C$0.00 – C$0.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About GenixPharmaceucticals Corporation
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
Financials
- Revenue (TTM)
- $68
- EBITDA
- $-124,839
- Profit Margin
- 0.00%
- ROE (TTM)
- -661.13%
- EPS (Diluted)
- -0.01
- Book Value
- -0.02
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About GENX
Articles Featuring GENX.V
Latest articles and analysis covering GENX.V
